UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore effective ways to earn money quickly from home. Use these strategies to boost your income without leaving your house.
19,961 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A surprising White House appearance between political rivals marks a new chapter in the fight over drug prices, with ...
Target delivered a solid beat-and-raise quarter, yet shares slid, illustrating a sell-the-news dynamic. With Walmart ...
Get an in-depth look at Paysafe (PSFE) 2026 earnings outlook. We break down Q1 results, revenue streams, margin trend...
A prominent fiduciary family office recently exited a sizable international value ETF position, prompting questions a...
Investors eyes turn to NextNav as 2025 earnings loom. This guide breaks down what to watch, potential growth drivers,...
Walmart faced a sharp reversal as investors priced in margin headwinds from fuel and weaker consumer demand. This art...
NVIDIA posted a blowout quarter as AI demand drives data-center growth, fueling bets that the company will form trill...
Barnes Noble clarifies Bookseller’s AI policy, saying it will not ban AI-written titles but will require clear labeli...
SoFi is growing fast, but a single metric could alter how you value the company. This article explains which number s...
Pi Network confronts a delay in its core upgrade as the PI price holds near $0.15. The ecosystem push and security wa...
As volatility eases, income-focused investors eye a dirt-cheap dividend powerhouse trading under $5. The article expl...